生物响应性介质性二氧化纳米颗粒用于触发药物释放
Neetu Singh1, Amrita Karambelkar, Luo Gu
1Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute Technology, Cambridge, Massachusetts 02139, USA.
Journal of the American Chemical Society
|October 11, 2011
概括
具有刺激反应的聚合物涂层的半孔化纳米粒子 (MSNPs) 为向药物输送提供了一种新的方法. 这些纳米颗粒特别在瘤部位释放多克索鲁比,诱导癌细胞死亡.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 半孔纳米粒子 (MSNPs) 是治疗剂的有希望的载体.
- 从MSNP中控制的体内药物释放仍然是一个重大挑战.
研究的目的:
- 合成和表征聚合物涂层MSNP用于触发药物释放.
- 评估这些纳米颗粒在提供抗瘤有效载荷方面的 in vivo 疗效.
主要方法:
- 对刺激反应的聚合物涂层MSNP的合成.
- 将多克索鲁比辛加载到核心和外领域.
- 药物排泄性质的体外表征.
- 在体内评估药物释放和瘤部位的治疗效果.
主要成果:
- 成功合成了能够封装治疗药物的聚合物涂层MSNP.
- 证明了体外受控的药物释放概况.
- 在瘤微环境中观察到蛋白酶触发的 doxorubicin 在体内释放.
- 在瘤细胞中确实诱导细胞亡.
结论:
- 聚合物涂层的MSNP使化学治疗药物的向和触发释放成为可能.
- 该平台显示了针对抗瘤有效载荷的具体交付的潜力,提高了治疗结果.
- 开发的纳米粒子为先进的癌症治疗提供了一个有前途的战略.
相关概念视频
Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...


